GlassScriptPhysician profile
Bethany Aguilar
NPI 1710569082
$3,294.21
in general payments reported to CMS, 2019-2025
26 companies · $1,356 in 2025
The $1,356 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $363 · 2022: $1,178 · 2023: $264 · 2024: $133 · 2025: $1,356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,668 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,667.53 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $824.08 | 2022-2025 | Odomzo, Blu-U, Winlevi |
| Abbvie INC. | $348.84 | 2021-2025 | |
| Janssen Biotech, INC. | $332.52 | 2021-2025 | Tremfya |
| Galderma Laboratories, L.P. | $208.64 | 2021-2025 | Nemluvio |
| Ucb, INC. | $195.36 | 2023-2025 | Bimzelx, Cimzia |
| Novartis Pharmaceuticals Corporation | $165.97 | 2022-2025 | |
| Pfizer INC. | $144.47 | 2025 | |
| Lilly USA, LLC | $134.35 | 2021-2025 | Ebglyss, Taltz |
| Genzyme Corporation | $131.52 | 2021-2025 | |
| Leo Pharma INC. | $101.73 | 2022-2025 | Adbry, Anzupgo |
| Janssen Scientific Affairs, LLC | $100.76 | 2021-2022 | |
| Dermavant Sciences, INC. | $95.46 | 2023 | Vtama |
| Incyte Corporation | $76.04 | 2022-2025 | Opzelura |
| Amgen INC. | $67.28 | 2021-2022 | |
| Lnhc, INC | $45.76 | 2025 | Zelsuvmi |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $43.12 | 2022-2023 | Dupixent |
| Merz North America, INC. | $41.78 | 2021-2022 | |
| Organon LLC | $39.73 | 2025 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $38.57 | 2025 | Cabtreo |
| E.R. Squibb & Sons, L.L.C. | $35.43 | 2023-2025 | Sotyktu |
| Almirall LLC | $30.86 | 2024 | Klisyri |
| Mayne Pharma Commercial LLC | $24.23 | 2025 | |
| Arcutis Biotherapeutics, INC. | $24.18 | 2025 | Zoryve |
| Paratek Pharmaceuticals, INC. | $21.85 | 2025 | Nuzyra |
| Genentech USA, INC. | $13.27 | 2022 | |
| Biofrontera INC. | $8.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bethany Aguilar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.